PQ 404
404. Deputy Michael Creed asked the Minister for Health if the drug luxturna which offers a cure for rare retinal disease has been reviewed by the HSE Rare Diseases Technology Review Committee; the status of the National Centre for Pharmacoeconomics negotiations on the availability of this drug; and if he will make a statement on the matter. [7177/22]
Introduced
10 February 2022
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
10 February 2022
Summary
404. Deputy Michael Creed asked the Minister for Health if the drug luxturna which offers a cure for rare retinal disease has been reviewed by the HSE Rare Diseases Technology Review Committee; the status of the National Centre for Pharmacoeconomics negotiations on the availability of this drug; and if he will make a statement on the matter. [7177/22]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 10 February 2022
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2022-02-10/404/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2022-02-10/pq_404